Recent Advances in Inflammation & Allergy Drug Discovery

Evaluation status available after sign-in

About the journal

Recent Advances in Inflammation & Allergy Drug Discovery is a journal in Netherlands. It is listed in MEDLINE according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

ISSN
2772-2716 · 2772-2708
Country
Netherlands
Access
Not open access / not declared

Index listings

  • MEDLINE · 2021-01-01
Indexing
MEDLINE
APC
—
Declared review time (DOAJ)
—
Actual review time (measured)
106 days received→accepted — computed from PubMed (n=99)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

156

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

8

i10-index

8

From OpenAlex open data (CC0).

Editorial & policy5
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
Portico
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
34%
ORCID iDs in current deposits
59%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Alternate titles
Recent advances in inflammation and allergy drug discovery
Source type
journal
NLM unique ID (PubMed)
101776469
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Dermatology and Skin Diseases
  • Dermatology and Skin Diseases
  • Pharmacological Effects of Natural Compounds
  • Pharmacological Effects of Natural Compounds
Show all subjects (50)
  • COVID-19 Clinical Research Studies
  • Asthma and respiratory diseases
  • South Asian Cinema and Culture
  • Ecocriticism and Environmental Literature
  • Inflammatory Bowel Disease
  • Educational Robotics and Engineering
  • Cinema and Media Studies
  • Human auditory perception and evaluation
  • Asthma and respiratory diseases
  • COVID-19 Clinical Research Studies
  • Allergic Rhinitis and Sensitization
  • Advanced Drug Delivery Systems
  • Pharmacology and Nanomedicine Research
  • Ecocriticism and Environmental Literature
  • South Asian Cinema and Culture
  • Inflammatory Bowel Disease
  • Gut microbiota and health
  • Educational Robotics and Engineering
  • Cinema and Media Studies
  • Human auditory perception and evaluation
  • Food Allergy and Anaphylaxis Research
  • Allergic Rhinitis and Sensitization
  • Inflammatory mediators and NSAID effects
  • Rheumatoid Arthritis Research and Therapies
  • Advanced Drug Delivery Systems
  • Pharmacology and Nanomedicine Research
  • Pancreatic function and diabetes
  • Food Allergy and Anaphylaxis Research
  • Inflammatory mediators and NSAID effects
  • Rheumatoid Arthritis Research and Therapies
  • Computational Drug Discovery Methods
  • Pancreatic function and diabetes
  • Advancements in Transdermal Drug Delivery
  • Synthesis and biological activity
  • Intellectual Property and Patents
  • Advancements in Transdermal Drug Delivery
  • Mesenchymal stem cell research
  • Intellectual Property and Patents
  • Synthesis and biological activity
  • Computational Drug Discovery Methods
  • Gut microbiota and health
  • Drug-Induced Adverse Reactions

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: